Review pending. Every figure has been located on its cited source page in an AI-assisted source verification (matched to the document's text) (17 October 2026). Independent review has not yet been carried out, and these pages are not indexed.AI-assisted source check done; independent review pending; not indexed. About the review
Omnicane
On this page
Company details
- Legal name
- Omnicane Limited
- Listing
- No ticker printed on the Stock Exchange of Mauritius, active (observed 2026-10-08)
- Sector
- Not classified (our classification from the stated principal activity)
- Financial year ends
- 31 December
Overview
Year ended 31 December 2025 · annual report, signed / final · source
Read with these figures
- Auditor's emphasis of matter. Key audit matters (opinion not modified): 'Impairment of investment in subsidiaries' (Company: investment of Rs 4.5 billion in subsidiaries carried at cost less impairment) and 'Recoverability of intercompany receivables' (Group and Company receivables from related parties of Rs 2.5 billion and Rs 5.0 billion, with expected credit losses of Rs 2.4 billion and Rs 3.5 billion) (report page 2(b), PDF p98, page image).
Full wording and sources
Auditor's emphasis of matter
Key audit matters (opinion not modified): 'Impairment of investment in subsidiaries' (Company: investment of Rs 4.5 billion in subsidiaries carried at cost less impairment) and 'Recoverability of intercompany receivables' (Group and Company receivables from related parties of Rs 2.5 billion and Rs 5.0 billion, with expected credit losses of Rs 2.4 billion and Rs 3.5 billion) (report page 2(b), PDF p98, page image).
Source: OMNICANE INTEGRATED REPORT 2025 (dated 2026-03-31)
-
Revenue
MUR 5.57 billion
5,570,636 MUR thousands · p102
−20.0% vs 2024
-
Operating profit / (loss)
MUR 431 million
430,943 MUR thousands · p102
−27.4% vs 2024
-
Profit / (loss) for the year
MUR 440 million
439,983 MUR thousands · p102
−25.5% vs 2024
-
Total assets
MUR 24.3 billion
24,277,715 MUR thousands · p103
+42.1% vs 2024
-
Total equity
MUR 10.6 billion
10,639,252 MUR thousands · p103
+45.5% vs 2024
-
Cash from operations
MUR 808 million
807,982 MUR thousands · p106
+207.3% vs 2024
Large amounts are rounded for reading (MUR million / billion / trillion); exact figures as printed are under each amount and in the tables. No currency conversion.
Financial statements
Exact figures as printed. Each column comes from one filing; labels are as printed in the newest filing. Amounts in MUR thousands unless the row says otherwise; brackets are negative.
† from a supplementary filing for the same year · ‡ signed audited statements preferred over a disputed figure · “–” is a printed dash, explained below the table
Column sources
- FY2025 — annual report, signed / final; reported for the year · source
- FY2024 — annual report, signed / final; comparative in the FY2025 filing · source
Income statement
| Line (as printed) | FY2025Annual reportreported for the year | FY2024Annual reportcomparative in FY2025 filing |
|---|---|---|
| Revenue | 5,570,636 | 6,965,655 |
| (Loss)/gain in fair value of consumable biological assets1 | (22,475) | 13,818 |
| Other operating income | 663,999 | 61,645 |
| Revenue and other operating income (unlabelled subtotal)2 | 6,212,160 | 7,041,118 |
| Operating expenses | (5,781,217) | (6,447,593) |
| Operating profit/(loss) | 430,943 | 593,525 |
| Impairment of assets and allowance for credit losses3 | (33,632) | 6,828 |
| Investment income4 | 10,105 | 6,652 |
| Finance costs | (447,883) | (442,102) |
| Other non-operating income5 | 348,015 | 388,146 |
| Fair value gain on investment properties6 | 123,478 | 29,563 |
| Share of results in associates7 | (513) | 315 |
| Share of results in joint ventures8 | 2,631 | –9 |
| Profit before taxation | 433,144 | 582,927 |
| Income tax charge | 6,839 | 7,513 |
| Profit for the year | 439,983 | 590,440 |
| Cash flow hedge10 | 3,334 | (59,773) |
| Translation differences arising on foreign operations11 | (5,785) | 132,906 |
| Changes in fair value of equity instruments at fair value through other comprehensive income12 | (32,382) | (2) |
| Change in value of land conversion rights13 | –14 | 1,841 |
| Change in fair value of freehold land15 | 2,636,218 | –14 |
| Remeasurements of retirement benefit obligations16 | 95,742 | 31,563 |
| Deferred tax effect on remeasurements of retirement benefit obligations17 | 11 | (57) |
| Other comprehensive income for the year | 2,697,138 | 106,478 |
| Total comprehensive income for the year | 3,137,121 | 696,918 |
| Non-controlling interests18 | 44,466 | 142,396 |
| Owners of the parent19 | 3,079,736 | 549,953 |
| Non-controlling interests20 | 57,385 | 146,965 |
- Printed “-”, read as nil: subtotal_arithmetic: is.profit_before_tax.
- Printed “-”, read as nil: subtotal_arithmetic: is.other_comprehensive_income.
Notes and alternative reported figures (18)
- “(Loss)/gain in fair value of consumable biological assets” is an issuer-specific line, not mapped to a shared definition: Note 25; added to revenue before operating expenses.
- “Revenue and other operating income (unlabelled subtotal)” is an issuer-specific line, not mapped to a shared definition: Printed unlabelled subtotal of revenue, the fair value change in consumable biological assets and other operating income.
- “Impairment of assets and allowance for credit losses” is an issuer-specific line, not mapped to a shared definition: Note 11: impairment of assets and expected credit losses combined.
- “Investment income” is an issuer-specific line, not mapped to a shared definition: Note 8.
- “Other non-operating income” is an issuer-specific line, not mapped to a shared definition: Note 10.
- “Fair value gain on investment properties” is an issuer-specific line, not mapped to a shared definition: Note 16.
- “Share of results in associates”: mapping to a shared definition is uncertain. Associates only; the share of results in joint ventures is printed on a separate line.
- “Share of results in joint ventures” is an issuer-specific line, not mapped to a shared definition: Note 20; printed apart from the share of results in associates.
- “Cash flow hedge” is an issuer-specific line, not mapped to a shared definition: OCI item that may be reclassified.
- “Translation differences arising on foreign operations” is an issuer-specific line, not mapped to a shared definition: OCI item that may be reclassified (note 29).
- “Changes in fair value of equity instruments at fair value through other comprehensive income” is an issuer-specific line, not mapped to a shared definition: OCI item not reclassified (note 21).
- “Change in value of land conversion rights” is an issuer-specific line, not mapped to a shared definition: OCI item not reclassified (note 17).
- “Change in fair value of freehold land” is an issuer-specific line, not mapped to a shared definition: OCI item not reclassified (note 14): revaluation of freehold land.
- “Remeasurements of retirement benefit obligations” is an issuer-specific line, not mapped to a shared definition: OCI item not reclassified (note 32).
- “Deferred tax effect on remeasurements of retirement benefit obligations” is an issuer-specific line, not mapped to a shared definition: OCI item not reclassified (note 23(d)).
- “Non-controlling interests” is an issuer-specific line, not mapped to a shared definition: Printed 'Non-controlling interests' under 'Profit attributable to:'.
- “Owners of the parent” is an issuer-specific line, not mapped to a shared definition: Printed 'Owners of the parent' under 'Total comprehensive income attributable to:'.
- “Non-controlling interests” is an issuer-specific line, not mapped to a shared definition: Printed 'Non-controlling interests' under 'Total comprehensive income attributable to:'.
Balance sheet
| Line (as printed) | FY2025Annual reportreported for the year | FY2024Annual reportcomparative in FY2025 filing |
|---|---|---|
| Property, plant and equipment | 13,229,853 | 10,981,476 |
| Right-of-use assets | 293,839 | 329,532 |
| Investment properties | 384,971 | 197,138 |
| Intangible assets | 766,466 | 761,687 |
| Investment in associates1 | 13,240 | 13,753 |
| Investment in joint ventures2 | 2,631 | –3 |
| Financial assets at FVOCI4 | 200,365 | 232,747 |
| Financial assets at amortised cost5 | 3,011,740 | 16,472 |
| Deferred tax assets | 79,436 | 62,430 |
| Total non-current assets | 17,982,541 | 12,595,235 |
| Inventories | 2,592,160 | 1,948,324 |
| Consumable biological assets6 | 178,229 | 200,704 |
| Trade receivables | 616,463 | 1,367,518 |
| Financial assets at amortised cost7 | 1,630,795 | 553,948 |
| Current tax assets | 27,108 | 85,425 |
| Cash in hand and at bank | 1,215,071 | 296,186 |
| Total current assets | 6,259,826 | 4,452,105 |
| Non-current assets classified as held for sale8 | 35,348 | 35,348 |
| Total assets | 24,277,715 | 17,082,688 |
| Share capital | 502,593 | 502,593 |
| Share premium | 292,450 | 292,450 |
| Revaluation and other reserves9 | 5,312,935 | 2,391,073 |
| Retained earnings | 3,246,717 | 2,887,982 |
| Owners’ interests | 9,354,695 | 6,074,098 |
| Non-controlling interests | 1,284,557 | 1,237,172 |
| Total equity | 10,639,252 | 7,311,270 |
| Borrowings | 4,086,377 | 4,431,932 |
| Lease liabilities | 105,040 | 132,992 |
| Financial liabilities10 | 2,826,509 | –11 |
| Deferred tax liabilities | 319,818 | 345,075 |
| Payable to related parties12 | –11 | –11 |
| Retirement benefit obligations | 437,484 | 533,014 |
| Total non-current liabilities | 7,775,228 | 5,443,013 |
| Payable to related parties13 | 62,329 | 24,884 |
| Trade and other payables | 2,080,069 | 2,137,226 |
| Financial liabilities14 | 970,360 | –15 |
| Current tax liabilities | 4,636 | 7,546 |
| Borrowings | 2,615,006 | 2,039,169 |
| Lease liabilities | 57,120 | 45,865 |
| Proposed dividend16 | 73,715 | 73,715 |
| Total current liabilities | 5,863,235 | 4,328,405 |
| Total equity and liabilities | 24,277,715 | 17,082,688 |
- Printed “-”, read as nil: subtotal_arithmetic: bs.non_current_assets.
- Printed “-”, read as nil: subtotal_arithmetic: bs.non_current_liabilities.
- Printed “-”, read as nil: subtotal_arithmetic: bs.current_liabilities.
Notes and alternative reported figures (13)
- “Investment in associates”: mapping to a shared definition is uncertain. Associates only; joint ventures are a separate line.
- “Investment in joint ventures” is an issuer-specific line, not mapped to a shared definition: Note 20; non-current.
- “Financial assets at FVOCI” is an issuer-specific line, not mapped to a shared definition: Note 21; non-current.
- “Financial assets at amortised cost” is an issuer-specific line, not mapped to a shared definition: Note 22; non-current.
- “Consumable biological assets” is an issuer-specific line, not mapped to a shared definition: Note 25; current.
- “Financial assets at amortised cost” is an issuer-specific line, not mapped to a shared definition: Note 22; current.
- “Non-current assets classified as held for sale” is an issuer-specific line, not mapped to a shared definition: Note 27; printed after total current assets.
- “Revaluation and other reserves” is an issuer-specific line, not mapped to a shared definition: Note 29: revaluation and other reserves combined.
- “Financial liabilities” is an issuer-specific line, not mapped to a shared definition: Note 35; non-current.
- “Payable to related parties” is an issuer-specific line, not mapped to a shared definition: Note 33; non-current.
- “Payable to related parties” is an issuer-specific line, not mapped to a shared definition: Note 33; current.
- “Financial liabilities” is an issuer-specific line, not mapped to a shared definition: Note 35; current.
- “Proposed dividend”: mapping to a shared definition is uncertain. Printed 'Proposed dividend' (note 37) as a current liability.
Cash flow
| Line (as printed) | FY2025Annual reportreported for the year | FY2024Annual reportcomparative in FY2025 filing |
|---|---|---|
| Operating profit/(loss) before working capital changes1 | 1,017,241 | 1,275,297 |
| Working capital requirements2 | 254,382 | (445,504) |
| Cash generated from operating activities (unlabelled subtotal) | 1,271,623 | 829,793 |
| Interest paid | (492,956) | (515,714) |
| Net tax paid | 29,315 | (51,115) |
| Net cash generated from operating activities | 807,982 | 262,964 |
| Purchase of property, plant and equipment | (457,951) | (251,772) |
| Purchase of intangible assets | (31,790) | (10,256) |
| Acquisition of subsidiaries3 | (400,000) | (77,733) |
| Acquisition of right-of-use assets4 | (27,093) | (19,318) |
| Proceeds from sale of land - net5 | 113,113 | 142,362 |
| Proceeds from sale of plant and equipment | 5,375 | 4,887 |
| Proceeds from redemption of shares by subsidiary6 | –7 | –7 |
| Interest received | 4,034 | 581 |
| Dividends received from subsidiary companies8 | –7 | –7 |
| Dividends received from available for sale investment9 | 6,071 | –7 |
| Net cash (used in)/from investing activities | (788,241) | (211,249) |
| Dividend paid to minority shareholders10 | (10,000) | (10,000) |
| Dividend paid to Company’s shareholders | (73,715) | (67,012) |
| Payments of long-term and short-term borrowings | (722,848) | (725,789) |
| Proceeds from long-term and short-term borrowings | 550,183 | 455,014 |
| Principal paid on lease liabilities | (35,458) | (71,776) |
| Repayment of import loans11 | –12 | (407,556) |
| Net cash (used in)/from financing activities | (291,838) | (827,119) |
| Movement in cash and cash equivalents | (272,097) | (775,404) |
| At January 1, | (634,445) | 79,951 |
| Acquisition of cash from subsidiaries13 | 919,274 | 1,232 |
| Effect of foreign exchange rate changes | 3,246 | 59,776 |
| At December 31, | 15,978 | (634,445) |
- Printed “-”, read as nil: subtotal_arithmetic: cf.cash_from_investing.
- Printed “-”, read as nil: subtotal_arithmetic: cf.cash_from_financing.
Notes and alternative reported figures (11)
- “Operating profit/(loss) before working capital changes” is an issuer-specific line, not mapped to a shared definition: Note 38(a).
- “Working capital requirements” is an issuer-specific line, not mapped to a shared definition: Note 38(b).
- “Acquisition of subsidiaries” is an issuer-specific line, not mapped to a shared definition: Investing (note 18(a),(b)).
- “Acquisition of right-of-use assets” is an issuer-specific line, not mapped to a shared definition: Investing (note 15).
- “Proceeds from sale of land - net” is an issuer-specific line, not mapped to a shared definition: Investing.
- “Proceeds from redemption of shares by subsidiary” is an issuer-specific line, not mapped to a shared definition: Investing; Company only.
- “Dividends received from subsidiary companies” is an issuer-specific line, not mapped to a shared definition: Investing; Company only.
- “Dividends received from available for sale investment” is an issuer-specific line, not mapped to a shared definition: Investing.
- “Dividend paid to minority shareholders” is an issuer-specific line, not mapped to a shared definition: Financing (note 36).
- “Repayment of import loans” is an issuer-specific line, not mapped to a shared definition: Financing (note 38(c)).
- “Acquisition of cash from subsidiaries” is an issuer-specific line, not mapped to a shared definition: Cash and cash equivalents of subsidiaries acquired, in the movement of cash.
Segments
Segment data not yet collected for this company in the pilot.
Dividends
Proposed or recommended, declared and paid are different events and are kept apart. A statement that no dividend was proposed does not mean none was paid.
| Year ended | Event | Wording as printed | Amount | Unit | Source |
|---|---|---|---|---|---|
| 31 Dec 2025 | Dividends paid (cash flow statement) | Dividend paid to Company’s shareholders |
(73,715) | MUR thousands | Annual report, p106 |
| 31 Dec 2024 | Dividends paid (cash flow statement) | Dividend paid to Company’s shareholders |
(67,012) | MUR thousands | Annual report, p106 |
Sources
Each filing used on this page, newest period first. Dates are the document's own; the date we retrieved a file is shown separately and is never a publication date.
-
OMNICANE INTEGRATED REPORT 2025
Year ended 31 December 2025 · Annual report · signed / final
Audit: RSM (Mauritius) LLP, unmodified opinion · signed
Auditor's sign-off: Ravi R Kowlessur, FCCA, for RSM (Mauritius) LLP
Final status: Independent auditor's report to the shareholders of Omnicane Limited, reproduced as page images (report pages 2(a)-2(d), PDF p98-p99): unmodified opinion on the consolidated and separate financial statements; handwritten signatures of RSM (Mauritius) LLP, Ebene, and Ravi R Kowlessur, FCCA, Licensed by FRC, with the stamped date 'Date: 31 MAR 2026' (p99). The report refers to the statements 'set out on pages 3 to 74' of the separately paginated financial statements, which are reproduced in this integrated report on folios 102-163. 'The financial statements have been approved for issue by the Board of Directors on March 31, 2026', signed by Jimmy Tong Sam (Chairperson) and Jacques M. D'Unienville (Chief Executive Officer) (p103, page image).
- Document date
- 31 Mar 2026
- Auditor's report
- 31 Mar 2026
- Board approval
- 31 Mar 2026
- Retrieved by us
- 8 Oct 2026 (not a publication date)
- Used for
- statement columns FY2025, FY2024
- Basis
- consolidated statements · MUR thousands (printed “Rs’000”)
- 'Income tax charge' is printed positive (6,839; 2024: 7,513) and added to profit before taxation (433,144) to give profit for the year (439,983), i.e. a net tax credit (p102). 'Net tax paid' is printed positive (29,315) for 2025 in operating cash flows (p106).
- The auditor's report is reproduced only as page images (no text layer). The archived derived page text of p103 (financial position) omits five printed rows (Financial assets at FVOCI; Financial assets at amortised cost, non-current and current; Financial liabilities, non-current and current), which the PDF's own text layer (pypdf, as the importer re-reads it) and the page render both show; the transcribed values match the render. No hidden figures differing from the printed page were found.
- The cash-flow statement's closing cash (15,978; 2024: (634,445)) is net of bank overdrafts (note 38(d)); 'Acquisition of cash from subsidiaries' 919,274 is added in the movement of cash (p106). Group financial liabilities (note 35) of 2,826,509 non-current and 970,360 current appear in 2025 only (p103).
Technical details
- File
- 178 pages, with a text layer
- SHA-256
d905fff7facd1a5ba3df50b95ffce5bf602f54c51fd0cfc94f164045978337bf- Entity as printed
- Omnicane Limited
- Issuer copy
- retrieved 2026-10-08T19:13:14Z
Data notes
No figure-level notes beyond those in the tables.
Review status: every figure has been located on its cited source page in an AI-assisted source verification (matched to the document's text) (17 October 2026). Independent review is pending for every figure; automated checks and the AI-assisted verification are not independent review.
Download
Figures shown on this page (CSV) — the same selected figures at their exact printed values, each with its source document, SHA-256, page, selection rule and reading. Independent review of these figures is pending.